Beyond inflammation: the multifaceted therapeutic potential of targeting the CXCL8-CXCR1/2 axis in type 1 diabetes
Identifying novel therapeutic targets involved in the multiple mechanisms underlying the complex pathophysiology of type 1 diabetes (T1D) could change the natural history of this disease. The CXCL8-CXCR1/2 axis is emerging as a therapeutic target with a crucial, multifaceted role in T1D pathophysiol...
Saved in:
| Main Authors: | Georgia Fousteri, Meghan Jones, Rubina Novelli, Serena Boccella, Laura Brandolini, Andrea Aramini, Paolo Pozzilli, Marcello Allegretti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1576371/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The CXCL12/CXCR4 Axis: An Emerging Therapeutic Target for Chronic Pain
by: Chen Z, et al.
Published: (2025-05-01) -
Biomarker Significance of Serum CXCL8, CXCL10 and CXCL16 in Breast Tumors of Iraqi Patients
by: Aseel F Khalaf, et al.
Published: (2020-03-01) -
Genetic Variants of Interleukin-8 and Interleukin-16 and Their Association with Cervical Cancer Risk
by: Rafał Watrowski, et al.
Published: (2025-01-01) -
Is a rare CXCL8 gene variant a new possible cause or course factor of inflammatory bowel disease?
by: Marcin Gabryel, et al.
Published: (2025-03-01) -
Corrigendum: Is a rare CXCL8 gene variant a new possible cause or course factor of inflammatory bowel disease?
by: Marcin Gabryel, et al.
Published: (2025-04-01)